July 10, 2023 ETH Zürich (Switzerland) and United States National Cancer Institute Sign Extension of MOU for Proteogenomics Cancer Research Learn More
August 18, 2022 Collaborating with Major International Partners – NCI Welcomes Renewed Commitments to the Cancer Moonshot with Australia, Canada, and Germany Learn More
June 1, 2022 NCI Welcomes Renewed Commitments to the Cancer Moonshot with Japan and the Republic of Korea Learn More
March 1, 2022 NCI’s International Cancer Proteogenome Consortium Welcomes Three New Member Institutions in the Global Fight Against Cancer Learn More
July 5, 2019 The National Cancer Center – Korea (NCC-K) Joins the International Cancer Proteogenomic Consortium (ICPC) Learn More
May 07, 2018 Indian Institute of Technology Bombay and Tata Memorial Centre Join the International Efforts in Clinical Proteogenomics Cancer Research Learn More
October 10, 2017 Korea University Joins the International Efforts in Clinical Proteogenomics Cancer Research Learn More
